PT90001A - Processo para a preparacao de derivados heterociclicos de etilenodiamina - Google Patents

Processo para a preparacao de derivados heterociclicos de etilenodiamina

Info

Publication number
PT90001A
PT90001A PT90001A PT9000189A PT90001A PT 90001 A PT90001 A PT 90001A PT 90001 A PT90001 A PT 90001A PT 9000189 A PT9000189 A PT 9000189A PT 90001 A PT90001 A PT 90001A
Authority
PT
Portugal
Prior art keywords
group
hydrogen
alkyl
het
hetero
Prior art date
Application number
PT90001A
Other languages
English (en)
Other versions
PT90001B (pt
Inventor
Vittorio Vecchietti
Giuseppe Giardina
Original Assignee
Zambeletti Spa L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888806210A external-priority patent/GB8806210D0/en
Priority claimed from GB888823562A external-priority patent/GB8823562D0/en
Application filed by Zambeletti Spa L filed Critical Zambeletti Spa L
Publication of PT90001A publication Critical patent/PT90001A/pt
Publication of PT90001B publication Critical patent/PT90001B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/42Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having etherified hydroxy groups and at least two amino groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT90001A 1988-03-16 1989-03-14 Processo para a preparacao de derivados heterociclicos de etilenodiamina PT90001B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888806210A GB8806210D0 (en) 1988-03-16 1988-03-16 Novel compounds
GB888823562A GB8823562D0 (en) 1988-10-07 1988-10-07 Novel compounds

Publications (2)

Publication Number Publication Date
PT90001A true PT90001A (pt) 1989-11-10
PT90001B PT90001B (pt) 1994-06-30

Family

ID=26293641

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90001A PT90001B (pt) 1988-03-16 1989-03-14 Processo para a preparacao de derivados heterociclicos de etilenodiamina

Country Status (14)

Country Link
US (1) US4999359A (pt)
EP (1) EP0333427B1 (pt)
JP (1) JPH02101062A (pt)
KR (1) KR890014478A (pt)
AT (1) ATE126802T1 (pt)
AU (1) AU616488B2 (pt)
CA (1) CA1336909C (pt)
DE (1) DE68923891T2 (pt)
DK (1) DK124089A (pt)
ES (1) ES2075849T3 (pt)
GR (1) GR3017213T3 (pt)
IE (1) IE67334B1 (pt)
NZ (1) NZ228331A (pt)
PT (1) PT90001B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8824400D0 (en) * 1988-10-18 1988-11-23 Glaxo Group Ltd Chemical compounds
GB8827479D0 (en) * 1988-11-24 1988-12-29 Zambeletti Spa L Novel compounds
DE3935371A1 (de) * 1988-12-23 1990-07-05 Merck Patent Gmbh Stickstoffhaltige ringverbindungen
GB8926560D0 (en) * 1989-11-24 1990-01-17 Zambeletti Spa L Pharmaceuticals
WO1991008206A1 (en) * 1989-11-24 1991-06-13 Dr. Lo. Zambeletti S.P.A. N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals
WO1991017116A1 (en) * 1990-04-28 1991-11-14 Dr. Lo. Zambeletti S.P.A. Novel 1-(2h-1-oxo-3,4-dihydronaphtyl-6)-acetyl-piperidines, process for their preparation and therapeutic use
GB9104839D0 (en) * 1991-03-07 1991-04-17 Zambeletti Spa L Novel compounds
WO1992018115A1 (en) * 1991-04-18 1992-10-29 Dr Lo Zambeletti S.P.A. Use of heterocyclic compounds for the treatment of inflammatory pain
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
EP0996434A4 (en) * 1997-07-14 2001-10-10 Adolor Corp ANTI-PRURITIC PHARMACEUTICAL COMPOSITIONS CONTAINING KAPPA RECEPTOR AGONISTS AND METHOD FOR TREATING PRURITUS USING THE SAME
US6645980B1 (en) 2000-05-25 2003-11-11 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
US6677332B1 (en) 1999-05-25 2004-01-13 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US7361666B2 (en) 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6635661B2 (en) 2000-05-25 2003-10-21 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
US6476046B1 (en) * 2000-12-04 2002-11-05 Sepracor, Inc. Diazabicyclo[4.3.0]nonanes, and methods of use thereof
CL2007002097A1 (es) 2006-07-20 2008-01-18 Smithkline Beecham Corp Compuestos derivados de pirrolidina o morfolina antagonistas de urotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar insuficiencia cardiaca congestiva, insuficiencia cardiaca isquemica, angina, isquemia del miocardio, vejiga hiperactiva, asma y/o copd, entre otras.
UY30892A1 (es) 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
MY161598A (en) 2009-01-30 2017-04-28 Glaxosmithkline Llc Crystalline n-{ (1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl} -5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
CA2781716A1 (en) 2009-12-04 2011-06-09 Sunovion Pharmaceuticals Inc. Multicyclic thieno compounds and use thereof for the treatment of a neurological disorder
AU2017301769B2 (en) 2016-07-29 2022-07-28 Pgi Drug Discovery Llc Compounds and compositions and uses thereof
SG10202100751YA (en) 2016-07-29 2021-03-30 Sunovion Pharmaceuticals Inc Compounds and compositions and uses thereof
EP3548613B1 (en) * 2016-12-02 2021-01-27 Fraunhofer Gesellschaft zur Förderung der Angewand Bacterial glutaminyl cyclase inhibitors and use thereof in the treatment of periodontitis
AU2018220509B2 (en) 2017-02-16 2022-04-28 Sumitomo Pharma America, Inc. Methods of treating schizophrenia
SG11202000669VA (en) 2017-08-02 2020-02-27 Sunovion Pharmaceuticals Inc Isochroman compounds and uses thereof
CA3091292A1 (en) 2018-02-16 2019-08-22 Sunovion Pharmaceuticals Inc. Salts, crystal forms, and production methods thereof
JP7703449B2 (ja) 2019-03-14 2025-07-07 スミトモ・ファーマ・アメリカ・インコーポレイテッド イソクロマニル化合物の塩およびその結晶体、ならびにそれらの製造方法、治療用途および医薬組成物
CN115734785A (zh) 2020-04-14 2023-03-03 桑诺维恩药品公司 (S)-(4,5-二氢-7H-噻吩并[2,3-c]吡喃-7-基)-N-甲基甲胺用于治疗神经和精神方面的病症

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601796D0 (en) * 1986-01-24 1986-02-26 Zambeletti Spa L Compounds
GB8618188D0 (en) * 1986-07-25 1986-09-03 Ici Plc Diamine compounds
DE3766335D1 (de) * 1986-09-17 1991-01-03 Zambeletti Spa L N-1-acylierte-(1-(phenyl- oder benzyl-))-1,2-aethylendiamine.
DE3935371A1 (de) * 1988-12-23 1990-07-05 Merck Patent Gmbh Stickstoffhaltige ringverbindungen

Also Published As

Publication number Publication date
EP0333427A1 (en) 1989-09-20
IE890816L (en) 1989-09-16
DE68923891D1 (de) 1995-09-28
CA1336909C (en) 1995-09-05
ATE126802T1 (de) 1995-09-15
PT90001B (pt) 1994-06-30
GR3017213T3 (en) 1995-11-30
IE67334B1 (en) 1996-03-20
ES2075849T3 (es) 1995-10-16
DK124089D0 (da) 1989-03-14
JPH02101062A (ja) 1990-04-12
DE68923891T2 (de) 1996-02-22
DK124089A (da) 1989-09-17
US4999359A (en) 1991-03-12
NZ228331A (en) 1991-10-25
EP0333427B1 (en) 1995-08-23
AU3131589A (en) 1989-09-21
AU616488B2 (en) 1991-10-31
KR890014478A (ko) 1989-10-23

Similar Documents

Publication Publication Date Title
PT90001A (pt) Processo para a preparacao de derivados heterociclicos de etilenodiamina
PT628311E (pt) Derivado de xantina com actividade antidepressiva
PT93111A (pt) Processo para a preparacao de compostos heterociclicos contendo pelo menos dois atomos de azoto no anel
NO179142C (no) 3-benzyliden-1-karbamoyl-2-pyrrolidon-analoger
PT90623A (pt) Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease
DK0565377T3 (da) Terapeutiske midler til behandling af Parkinsons sygdom
PT89746B (pt) Processo para a preparacao de derivados de isoquinolina
PT90740A (pt) Processo para a preparacao de oligopeptideos com aminoacidos analogos de prolina ciclicos, e de composicoes farmaceuticas que os contem
PT94711A (pt) Processo para a preparacao de derivados de isoquinolina
PT89677A (pt) Processo para a preparacao de novos derivados azaciclicos, em particular derivados de piperidina
ATE124940T1 (de) Oximderivate von formylpyridylimidazolinone, deren herbizide verwendung und verfahren zu deren herstellung.
ATE137747T1 (de) Aminobenzolverbindungen, herstellung und verwendung
EP0726269A4 (en) QUINOLINE CARBONIC ACID DERIVATIVE AND ITS SALTS
DE3678460D1 (de) Imidazolderivate, verfahren zu deren herstellung und deren anwendung als fungizide.
BR8703865A (pt) Processo para a preparacao de misturas de isomeros e/z e isomeros z puros de derivados de nalfa-(2-ciano-2-alcoximinoacetil)-aminoacidos e dos correspondentes peptidios,composicoes fungicidas,processos para o combate de pragas e para a preparacao de composicoes
PT83975B (pt) Processo para a preparacao de derivados de 5-aminoalquil-beta-carbolinas e de composicoes farmaceuticas que os contem
DE69004596D1 (de) Benzodiazepin-Analoge.
IT1213219B (it) Derivati amminoalchilnaftalenici ad attivita' farmacologica.
ATE96026T1 (de) Verwendung heterozyklischer amide zur verhinderung der tumormetastasierung.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19931209

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19970630